Hydrochloric Acid → 1-(4-(6-(3-Aminopiperidin-1-yl)pyridin-3-ylamino)-6-(3-chloro-5-fluoro-4-hydroxyphenyl)quinolin-3-yl)ethanone
Reaction equation
[C:1]([C:4]1[CH:5]=[N:6][C:7]2[C:12]([C:13]=1[NH:14][C:15]1[CH:16]=[CH:17][C:18]([N:21]3[CH2:26][CH2:25][CH2:24][CH:23]([NH:27]C(=O)OC(C)(C)C)[CH2:22]3)=[N:19][CH:20]=1)=[CH:11][C:10]([C:35]1[CH:40]=[C:39]([F:41])[C:38]([OH:42])=[C:37]([Cl:43])[CH:36]=1)=[CH:9][CH:8]=2)(=[O:3])[CH3:2].Cl>ClCCl.C(OCC)C>[NH2:27][CH:23]1[CH2:24][CH2:25][CH2:26][N:21]([C:18]2[N:19]=[CH:20][C:15]([NH:14][C:13]3[C:12]4[C:7](=[CH:8][CH:9]=[C:10]([C:35]5[CH:40]=[C:39]([F:41])[C:38]([OH:42])=[C:37]([Cl:43])[CH:36]=5)[CH:11]=4)[N:6]=[CH:5][C:4]=3[C:1](=[O:3])[CH3:2])=[CH:16][CH:17]=2)[CH2:22]1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
tert-butyl 1-(5-(3-acetyl-6-(3-chloro-5-fluoro-4-hydroxyphenyl)quinolin-4-ylamino)pyridin-2-yl)piperidin-3-ylcarbamate (80 mg, 0.132 mmol) was dissolved in dichloromethane (5 mL). To this solution was added a 2.0 M HCl solution in diethyl ether (2 mL) the mixture was stirred for 16 h at room temperature where a precipitate formed. The precipitate was filtered off, washed with dichloromethane (10 mL), dried under vacuum to obtain the desired product as the HCl salt (30 mg, 45%) as a yellow-orange solid: 1H NMR (500 MHz, MeOD) δ 9.26 (s, 1H), 8.24 (d, J=2.9 Hz, 1H), 8.20 (dd, J=8.9, 1.9 Hz, 1H), 7.99 (d, J=8.9 Hz, 1H), 7.95 (d, J=2.0 Hz, 1H), 7.68 (dd, J=9.1, 2.8 Hz, 1H), 7.11 (d, J=9.1 Hz, 1H), 7.04 (m, 2H), 4.54 (s, 1H), 4.02 (d, J=12.7 Hz, 1H), 2.80 (s, 3H), 2.18 (m, 1H), 1.94 (m, 1H), 1.74 (m, 2H); ESI MS m/z 506, [C27H25ClFN5O2+H]+; HPLC 95.2% (AUC), tR=10.84 min.
Workup
- customformed
- filtrationThe precipitate was filtered off
- washwashed with dichloromethane (10 mL)
- customdried under vacuum
Sources & evidence
- ORD record
- ord-5f03ef408fdc4534a84f45bb0f8c158b
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…